PATENT CLAIM ANALYSIS

Application Number: 15996162
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2019-04
Patent Classification: ["514", "275000"]

Abstract:
The present invention provides compounds, pharmaceutically acceptable compositions thereof, and methods of using the same.

Claim (Index 92):
The method according to  claim 68 , wherein the disorder is a TEC-kinase-mediated disorder selected from an autoimmune disorder, an inflammatory disorder, a proliferative disorder, a hyperproliferative disease, an immunological-mediated diseases, a disease of the respiratory tract, a disease of the bone and joints, a skin disorder, a gastrointestinal disorder, a systemic disease, or allograft rejection.

Metadata:
- Claim Count in Document: 65.0
- Percentile: 94.0
- Lexical Diversity: 1.05882
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13670937', '13671129', '15080351', '12492180', '14296376']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.9086010150185886
- 35 USC 102 Novelty (BERT): 0.5876769159546753
- Combined Prediction Score: 0.8765086051121973
- Mean Citation Score: 656.062982
- Max Citation Score: 695.6846
- Similarity Product: 369.89650748741633

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test